NYSE:TEVA

Teva Pharmaceutical Industries Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy TEVA

*Your capital is at risk

$32.83

-0.250 (-0.756%)

At Close: Jun 03, 2026

Teva Pharmaceutical Industries Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -58.65. In total, the insiders bought 2.18M and sold 783.74K TEVA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-58.65
● Buy	2.18M shares
● Sell	783.74K shares
76% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Mar 03, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -58.65. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (76% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 28, 2026 Buy	Restricted Share Units A-Award	Zaks Tal Zvi Director	Director	7 242 Value: $250.0K
May 28, 2026 Buy	Restricted Share Units A-Award	Satchi-fainaro Ronit Director	Director	7 242 Value: $250.0K
May 28, 2026 Buy	Restricted Share Units A-Award	Nisen Perry Director	Director	7 242 Value: $250.0K
May 28, 2026 Buy	Restricted Share Units A-Award	Lieberman Gerald M Director	Director	7 242 Value: $250.0K
May 28, 2026 Buy	Restricted Share Units A-Award	Elstein Amir Director	Director	7 242 Value: $250.0K
May 28, 2026 Buy	Restricted Share Units A-Award	Crane Rosemary A Director	Director	7 242 Value: $250.0K
May 28, 2026 Buy	Restricted Share Units A-Award	Lichtenstein Chen Director	Director	7 242 Value: $250.0K
May 28, 2026 Buy	Restricted Share Units A-Award	Barer Sol J Director	Director	10 863 Value: $375.0K
May 28, 2026 Buy	Restricted Share Units A-Award	Mignone Roberto Director	Director	7 242 Value: $250.0K
May 14, 2026 Buy	Ordinary Shares M-Exempt	Lippman Evan EVP, Business Development	Officer	74 008 Value: $2.61M
May 14, 2026 Sell	Ordinary Shares S-Sale	Lippman Evan EVP, Business Development	Officer	35 912 Value: $1.28M
May 14, 2026 Buy	Restricted Share Units M-Exempt	Lippman Evan EVP, Business Development	Officer	11 841 Value: $418.1K
May 14, 2026 Buy	Ordinary Shares M-Exempt	Lippman Evan EVP, Business Development	Officer	11 841 Value: $418.1K
May 14, 2026 Sell	Ordinary Shares S-Sale	Lippman Evan EVP, Business Development	Officer	5 746 Value: $204.5K
May 14, 2026 Sell	Ordinary Shares S-Sale	Kalif Eliyahu Sharon EVP, Chief Financial Officer	C-Suite Officer	153 251 Value: $5.46M
May 14, 2026 Buy	Restricted Share Units M-Exempt	Lippman Evan EVP, Business Development	Officer	74 008 Value: $2.61M
May 06, 2026 Sell	Ordinary Shares S-Sale	Weiss Amir Chief Accounting Officer	Officer	10 679 Value: $384.4K
May 05, 2026 Sell	Ordinary Shares S-Sale	Daniell Richard EVP, Europe Commercial	Officer	30 000 Value: $1.06M
May 01, 2026 Sell	Ordinary Shares S-Sale	Sabag Mark See "remarks"	Officer	144 180 Value: $5.05M
Apr 30, 2026 Sell	Ordinary Shares S-Sale	Fox Christine EVP, U.s. Commercial	Officer	21 258 Value: $750.6K
Mar 17, 2026 Sell	Ordinary Shares S-Sale	Sabag Mark See "remarks"	Officer	62 102 Value: $1.87M
Mar 05, 2026 Sell	Ordinary Shares S-Sale	Shields Matthew EVP, Global Operations	Officer	17 295 Value: $547.7K
Mar 05, 2026 Buy	Ordinary Shares M-Exempt	Shields Matthew EVP, Global Operations	Officer	17 295 Value: $549.1K
Mar 05, 2026 Buy	Ordinary Shares M-Exempt	Savage Brian Interim Chief Legal Officer	Officer	3 580 Value: $113.7K
Mar 05, 2026 Sell	Ordinary Shares S-Sale	Savage Brian Interim Chief Legal Officer	Officer	1 127 Value: $35.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and cr...

Read Full Profile Here